KO
44
2
PLD
48
-5
MDT
62
3
PNR
69
4
STZ
57
2
COST
63
5
FRT
45
6
XYL
45
8
DOW
34
4
PPG
60
3
F
47
4
GILD
49
2
IBM
60
6
CFG
64
2
UA
59
14
ETN
79
4
TROW
51
3
CMS
60
2
VRSK
77
4
SHW
65
7
KO
44
2
PLD
48
-5
MDT
62
3
PNR
69
4
STZ
57
2
COST
63
5
FRT
45
6
XYL
45
8
DOW
34
4
PPG
60
3
F
47
4
GILD
49
2
IBM
60
6
CFG
64
2
UA
59
14
ETN
79
4
TROW
51
3
CMS
60
2
VRSK
77
4
SHW
65
7
Financhill
Back

Cassava Sciences 10K Form

Buy
63

SAVA
Cassava Sciences

Last Price:
26.49
Seasonality Move:
47.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.12M
Cash Flow: $-18.31M
Price / Cash Flow: 0
Annual Sales: $3.47
Price / Book: 9.29

Profitability

EPS (TTM): -1.38000
Net Income (TTM): $-17.66M
Gross Margin: $20.56M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.77% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAVA Technical Analysis vs Fundamental Analysis

Buy
63
Cassava Sciences (SAVA) is a Buy

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Buy
    The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.